| Literature DB >> 31337942 |
Rashed Almousa1,2, Xin Wen1, Gregory G Anderson3, Dong Xie1.
Abstract
A new BisGMA-based antibacterial dental composite has been formulated and evaluated. Compressive strength and bacterial viability were utilized to evaluate the formed composites. It was found that the new composite exhibited a significantly enhanced antibacterial function along with improved mechanical and physical properties. The bromine-containing derivative-modified composite was more potent in antibacterial activity than the chlorine-containing composite. The modified composites also exhibited an increase of 30-53% in compressive yield strength, 15-30% in compressive modulus, 15-33% in diametral tensile strength and 6-20% in flexural strength, and a decrease of 57-76% in bacterial viability, 23-37% in water sorption, 8-15% in shrinkage, 8-13% in compressive strength, and similar degree of conversion, than unmodified composite. It appears that this experimental composite may possibly be introduced to dental clinics as an attractive dental restorative due to its improved properties as well as enhanced antibacterial function.Entities:
Keywords: Antibacterial; Bacterial viability; Composite; Mechanical strength
Year: 2019 PMID: 31337942 PMCID: PMC6626271 DOI: 10.1016/j.sdentj.2019.03.009
Source DB: PubMed Journal: Saudi Dent J ISSN: 1013-9052
Fig. 1Synthesis scheme and structures of used chemicals.
The characteristic peaks from 1HNMR and FT-IR spectra.
| Code | The characteristic peaks from 1HNMR and FT-IR spectra |
|---|---|
| 2,3-Dichloro-4-oxobutenoic acid | 3361 (O—H stretching), 1765 (C |
| Bis(methacryloyloxy)propanol | 3490 (O—H stretching), 1720 (C |
| BCF | 1795 and 1721 (C |
| 2,3-Dichloro-4-oxobutenoic acid | 6.25 (—CH), 3.45 (—OH) |
| Bis(methacryloyloxy)propanol | 6.42 (2H, C |
| BCF | 6.35 (2H, C |
Fig. 2CS and modulus of the experimental antibacterial composites: (a) CS; (b) Modulus.
Fig. 3Bacterial viability of the experimental antibacterial composites with three bacterial species: (a) BCF-based; (b) BBF-based.
Fig. 4Bacterial images after incubating with antibacterial composites vs. control for 48 h: (a) untreated S. mutans, (b) S. mutans with BT, (c) S. mutans with BTBCF7525, (d) S. mutans with BTBCF5050, (e) S. mutans with BTBCF2575, (f) S. mutans with BTBBF7525, (g) S. aureus with BTBCF2575, and (h) P. aeruginosa with BTBCF2575.
Properties of the studied composites.1
| Material | YS [MPa] | M [GPa] | CS [MPa] | DTS [MPa] | FS [MPa] | WS [µg/mm3] | Shrinkage [%] | DC [%] |
|---|---|---|---|---|---|---|---|---|
| BT | 116.9 (3.0) | 5.51 (0.10) | 323.7 (10)a, | 42.8 (5.4)b | 84.6 (5.9)c | 26.4 (1.8) | 3.9 (0.29) | 72.1 (1.7)d |
| BTBCF | 153.1 (2.4) | 6.34 (0.12) | 280.5 (8.9) | 49.2 (5.8)b | 89.5 (4.2)c | 20.2 (1.3) | 3.6 (0.23) | 69.4 (1.1)d |
| BTBBF | 177.9 (1.1) | 7.16 (0.06) | 314.9 (5.9)a | 56.9 (4.9) | 101.7 (8.8) | 16.5 (0.9) | 3.3 (0.11) | 67.9 (1.5)d |
BT = BisGMA/TEGDMA = 50/50 (wt/wt); BTBCF = BT/BCF = 50/50; BTBBF = BT/BBF = 50/50.
Entries are mean values with standard deviations in parentheses, where the mean values with the same superscript letter were not significantly different from each other (p > 0.05). Samples for strength tests were conditioned in distilled water at 37 °C for 24 h before testing.